Lv21
170 积分 2026-02-12 加入
Relapsed refractory multiple myeloma: a comprehensive overview
13天前
已完结
Estimate of Multiple Myeloma Patients by Line of Therapy in the USA: Population-Level Projections 2020–2025
13天前
已完结
PDE-5 Inhibitors: Clinical Points
21天前
已完结
Model‐Supported Development of CS‐8635: A Fixed‐Dose Combination of Olmesartan, Amlodipine, and Hydrochlorothiazide
24天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
1个月前
已完结
The expanding landscape of GLP-1 medicines
1个月前
已完结
Exploratory Food Effect Assessment in Patients in Early Clinical Development of Oncology Drugs
1个月前
已完结
A Phase I clinical trial of lodenafil carbonate, a new phosphodiesterase Type 5 (PDE5) inhibitor, in healthy male volunteers
1个月前
已完结
A Phase I Study to Show the Relative Bioavailability and Bioequivalence of Fixed-Dose Combinations of Ambrisentan and Tadalafil in Healthy Subjects
1个月前
已完结
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
1个月前
已完结
皖公网安备34019202002308
